Form 8-K - Current report:
SEC Accession No. 0001140361-25-005570
Filing Date
2025-02-24
Accepted
2025-02-24 08:00:16
Documents
15
Period of Report
2025-02-24
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044166_8k.htm   iXBRL 8-K 29103
2 EXHIBIT 99.1 ef20044166_ex99-1.htm EX-99.1 19474
6 image0.jpg GRAPHIC 18042
  Complete submission text file 0001140361-25-005570.txt   215150

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA insm-20250224.xsd EX-101.SCH 3976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20250224_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20250224_pre.xml EX-101.PRE 16040
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20044166_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 25654267
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)